Meal timing may change how this drug enters the bloodstream

NCT ID NCT07662798

Recruiting now Knowledge-focused Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study looks at how eating a high-fat or low-fat meal changes the way the body absorbs the drug tersolisib. Healthy volunteers receive two doses of tersolisib—one on an empty stomach and one with a meal—and have blood tests to measure drug levels. The goal is to understand whether food affects how much of the drug gets into the bloodstream, which can guide future dosing instructions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tersolisib
What this could lead to: Results could help determine whether tersolisib should be taken with or without food for best absorption.
What could go wrong: This is an early-phase study in healthy people, not patients. Findings may not predict real-world use or safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Locations

ICON Early Phase Services, LLC
RECRUITING

San Antonio, Texas, 78232, United States
Lenexa Clinic
RECRUITING

Lenexa, Kansas, 66219, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.